News

AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply ...
The global fish peptones market, valued at approximately USD 1,746.9 million in 2025, is projected to grow at a steady CAGR ...
EKF Diagnostics said in an update on Monday that it made good progress in the first half of 2025, with strong operational ...
M.M.R.V. vaccine: This combination vaccine for measles, mumps, rubella and chickenpox is on the agenda under “proposed recommendations” regarding its use in children younger than 4.